Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients with Acute Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT06007911
What this trial is testing

Venetoclax-Navitoclax With Cladribine-based Salvage Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed Adult AMLRefractory AML
Medical College of Wisconsin
Large-scale testing (Phase 3)Not Yet RecruitingNCT06673459
What this trial is testing

BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients

Who this might be right for
T-Cell Lymphocytic LeukemiaALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONTotal Body Irradiation+1 more
The First Affiliated Hospital of Soochow University 430
Early research (Phase 1)Study completedNCT00101179
What this trial is testing

MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic Leukemiade Novo Myelodysplastic Syndrome+5 more
National Cancer Institute (NCI) 63
Not applicableNot Yet RecruitingNCT07717164
What this trial is testing

PRAISE-IR Versus CIBMTR Controls

Who this might be right for
ALL (Acute B-Lymphoblastic Leukemia)AML (Acute Myeloid Leukemia)MDS (Myelodysplastic Syndrome)
Miltenyi Biomedicine GmbH 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT00792948
What this trial is testing

Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1+4 more
National Cancer Institute (NCI) 97
Not applicableStudy completedNCT02823132
What this trial is testing

Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acute Leukemia

Who this might be right for
Acute LeukemiaInvasive Fungal Infection
Centre Hospitalier Universitaire Dijon 134
Testing effectiveness (Phase 2)Study completedNCT01736943
What this trial is testing

Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous Leukemia
Joseph Tuscano 25
Early research (Phase 1)WithdrawnNCT03752138
What this trial is testing

TK216 and Decitabine in Treating Patients With Relapsed and Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT04139434
What this trial is testing

Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML

Who this might be right for
AML/MDSCMMLRelapse+3 more
Newave Pharmaceutical Inc 32
Testing effectiveness (Phase 2)Ended earlyNCT01383447
What this trial is testing

Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Who this might be right for
Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic LeukemiaRecurrent Adult Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Study completedNCT00003255
What this trial is testing

Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 38
Not applicableStudy completedNCT03123887
What this trial is testing

Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL

Who this might be right for
B-precursor Acute Lymphoblastic Leukemia
Harbin Hematology and Oncology Institute 632
Testing effectiveness (Phase 2)Study completedNCT01088984
What this trial is testing

Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Leukemia
Teva Branded Pharmaceutical Products R&D, Inc. 43
Testing effectiveness (Phase 2)Study completedNCT00764231
What this trial is testing

A Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid LeukemiaExerciseFatigue+1 more
Toronto Rehabilitation Institute 40
Early research (Phase 1)Study completedNCT00642031
What this trial is testing

Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesLeukemia
Prescient Therapeutics, Ltd. 20
Not applicableUnknownNCT05601895
What this trial is testing

The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or Without Sorafenib Maintenance

Who this might be right for
Acute LeukemiaAllogeneic Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 60
Testing effectiveness (Phase 2)Study completedNCT03303339
What this trial is testing

Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Cardiff Oncology 72
Early research (Phase 1)Study completedNCT03672695
What this trial is testing

Phase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia.

Who this might be right for
Acute Myeloid Leukaemia
Institut de Recherches Internationales Servier 37
Not applicableLooking for participantsNCT06508775
What this trial is testing

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

Who this might be right for
Melanoma Stage IIIB-cell Non Hodgkin LymphomaPediatric ALL+4 more
Miltenyi Biomedicine GmbH 40
Large-scale testing (Phase 3)Study completedNCT01147939
What this trial is testing

Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
Clavis Pharma 381
Next Page